Black Diamond Therapeutics, Inc. (BDTX)
3.35
+0.20
(+6.35%)
USD |
NASDAQ |
Apr 22, 16:00
3.365
+0.02
(+0.45%)
After-Hours: 06:58
Black Diamond Therapeutics EPS Diluted (Quarterly) : -0.2648 for Dec. 31, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Johnson & Johnson | 2.141 |
| Editas Medicine, Inc. | -0.0578 |
| Bionano Genomics, Inc. | -0.7386 |
| IDEAYA Biosciences, Inc. | -0.9401 |
| ACADIA Pharmaceuticals, Inc. | 1.596 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -15.12M |
| Total Expenses (Quarterly) | 15.12M |
| Enterprise Value | 82.05M |
| Earnings Yield | 11.36% |
| Operating Earnings Yield | 10.38% |
| Normalized Earnings Yield | 14.04 |